AcuraStem is harnessing human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in ALS and other disorders of the CNS.
Location: United States, California, Monrovia
Employees: 11-50
Total raised: $7M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Keiretsu F... | keiretsufo... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.01.2024 | Grant | $7M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 30.01.2024 | AcuraStem Secures $7M in Grant Funding | AcuraStem, a Pasadena, CA-based patient-based biotechnology company advancing treatments for neurode... | finsmes.co... |
| 19.06.2018 | AcuraStem Gets $3.7 Million Grant to Treat ALS | - | labusiness... |
| - | AcuraStem: Patient-Based Drug Discovery Platform Company Sec... | AcuraStem – a patient-based biotechnology company advancing treatments for amyotrophic lateral scler... | pulse2.com... |